Jasper Therapeutics, Inc. (NASDAQ:JSPR) Given Average Rating of “Buy” by Analysts
Shares of Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) have been assigned an average rating of “Buy” from the nine brokerages that are currently covering the firm, Marketbeat reports. Nine equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have issued ratings on the […]
Shares of Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) have been assigned an average rating of “Buy” from the nine brokerages that are currently covering the firm, Marketbeat reports. Nine equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have issued ratings on the […]
